Skip to main content
Premium Trial:

Request an Annual Quote

St. Joseph's Hospital to Offer Castle Biosciences Test

NEW YORK (GenomeWeb News) – St. Joseph's Hospital and Medical Center in Phoenix, Ariz., said today that it will offer a pharmacogenetic test for a brain cancer drug made by Castle Biosciences.

Under the partnership, the St. Joseph's DNA Diagnostics Lab will perform Castle Biosciences' test to find out if a drug is likely to benefit certain glioblastoma multiforme patients. The DecisionDx-GBM test will tell a doctor if a tumor is likely to be sensitive or resistant to the standard first-line treatment, information that would save doctors time and help them plan their treatment approach.

St. Joseph's said it is the only lab to offer the test, and that doctors from around the US are sending samples to its lab for testing. The test is not yet available for ordering in California and New York, but the lab said it is pursuing licenses for those states.

The agreement was worked out with assistance from the Greater Phoenix Economic Council.
Our offering this test is a prime example of translational genomics closing the loop between the research lab and the clinic," said John Stone, who heads the DNA Diagnostics Lab at St. Joseph's. "While there is currently no cure, this test can certainly help patients understand and plan for the likely course of the disease."

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.